The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020.
REUTERS/Wolfgang Rattay Acquire Licensing RightsLONDON, Aug 25 (Reuters) - Bayer (BAYGn.DE) is a "conglomerate" that needs to make major changes including "de-merging" two of its three business arms, investor Artisan Partners told Reuters on Friday.
"Recently we wrote a letter to the conglomerate Bayer -- and it is a conglomerate," David Samra, founding portfolio manager of Artisan's International Value team, said in an interview.
Bayer has a "whole host of problems" including "too much debt," Samra said.
Artisan is Bayer's sixth biggest investor, according to Refinitiv data.
Persons:
Wolfgang Rattay, David Samra, Bayer, Samra, Richa Naidu, Matt Scuffham
Organizations:
Bayer AG, REUTERS, Bayer, Artisan Partners, Reuters, Artisan's, Thomson
Locations:
Leverkusen, Germany